Listen to this Post
Introduction: A Legal Battle That Continues to Shape the Future of Wearable Health Technology
Apple’s ambitions in digital health have transformed the Apple Watch into one of the world’s most recognizable wearable devices. From heart-rate tracking to ECG readings and blood oxygen monitoring, the smartwatch has become a powerful health companion for millions of users. However, behind these innovations lies one of the technology industry’s longest and most expensive patent disputes.
A U.S. federal judge has now dealt another significant blow to Apple by refusing to overturn a jury verdict that ordered the company to pay $634 million in damages to medical technology firm Masimo. The decision represents another chapter in a legal conflict that has stretched over several years and could continue through future appeals.
The Origins of the Apple vs. Masimo Conflict
The dispute began in early 2020 when medical technology company Masimo accused Apple of unlawfully using its intellectual property related to pulse oximetry and optical health-monitoring technologies.
Masimo claimed Apple recruited several of its employees before integrating similar technologies into the Apple Watch. According to the lawsuit, Apple not only infringed multiple patents but also benefited from confidential knowledge that helped accelerate development of health-monitoring capabilities.
Apple has consistently denied wrongdoing, arguing that its products were independently developed and that many of Masimo’s patents were either invalid or unrelated to the Apple Watch’s implementation.
Years of Courtroom Battles
The legal dispute quickly expanded into several different courts and government agencies.
One of
The decision forced Apple to temporarily stop selling affected devices in the United States before eventually resuming sales after disabling the blood oxygen feature on impacted models.
The dispute became one of the highest-profile patent cases involving wearable technology, drawing attention from both the medical industry and consumer electronics sector.
Apple’s Technical Redesign
Rather than abandoning blood oxygen monitoring entirely, Apple redesigned the feature.
In 2025, the company introduced a new implementation where much of the processing and calculations occurred on the paired iPhone instead of directly on the Apple Watch. Health data would then appear inside Apple’s Health application.
The redesign represented
Masimo, however, challenged this redesign as well, filing another lawsuit against U.S. Customs and Border Protection after the agency permitted imports of the modified Apple Watches.
The $634 Million Jury Verdict
While the International Trade Commission dispute continued separately, another portion of Masimo’s original lawsuit proceeded in federal court.
In November 2025, a California jury concluded that Apple’s heart-rate monitoring and notification technologies infringed one of Masimo’s patents related to pulse oximetry.
The jury ordered Apple to pay approximately $634 million in damages.
Although the disputed patent expired in 2022, the jury determined that Apple had infringed it during its active lifetime, making Apple financially responsible for past infringement.
Apple Attempted to Overturn the Decision
Following the massive financial judgment, Apple sought to reverse the verdict.
The company requested either:
A judgment in its favor despite the
A completely new trial.
Apple argued that its smartwatch should not legally qualify as a “patient monitor,” which was a central requirement under Masimo’s patent claims.
According to Apple, the patent should only apply to traditional hospital-grade monitoring equipment rather than consumer wearable devices.
Judge Rejects
U.S. District Judge James V. Selna rejected
The judge agreed with the jury that the language used within the patent should be interpreted broadly enough to include devices such as the Apple Watch.
Rather than limiting the definition to specialized medical equipment, the court found that consumer wearable technology capable of monitoring patients could reasonably fall within the patent’s scope.
This interpretation became one of the key reasons Apple failed to overturn the verdict.
No New Trial Will Be Granted
Apple also argued that procedural mistakes during the original trial justified another hearing.
Among its complaints were objections to jury instructions and the exclusion of testimony from one of Apple’s expert witnesses.
Judge Selna rejected those arguments as well.
According to the ruling, none of the alleged issues were serious enough to undermine the fairness of the original proceedings.
As a result, the
Apple Plans to Continue Fighting
Apple responded by reiterating its long-standing position.
The company stated that Masimo primarily manufactures medical devices rather than consumer electronics and has pursued Apple through numerous lawsuits involving more than twenty-five patents.
Apple further argued that most of those patents have already been ruled invalid and emphasized that the patent involved in the current verdict expired several years ago.
Despite the latest setback, Apple confirmed that it intends to appeal the ruling.
Why This Case Matters Beyond Apple
The dispute highlights a broader challenge facing the wearable technology industry.
As smartwatches become increasingly sophisticated medical companions, the boundaries between traditional healthcare equipment and consumer electronics continue to blur.
Companies developing health-monitoring features must navigate an increasingly complex landscape of medical patents while simultaneously competing to deliver innovative products.
The outcome of this litigation could influence how future courts interpret patents covering wearable health technologies.
Deep Analysis
Command: Examine Patent Protection
Patents remain one of the strongest competitive weapons in healthcare technology.
Companies investing decades into sensor research expect legal protection when competitors commercialize similar innovations.
This case demonstrates how intellectual property can become just as valuable as the hardware itself.
Command: Analyze
Apple has consistently chosen to redesign products rather than permanently remove popular features.
Instead of abandoning blood oxygen monitoring, the company engineered alternative technical solutions while simultaneously continuing its legal defense.
This reflects
Command: Evaluate
Masimo has positioned itself as a defender of medical innovation.
Rather than competing directly in mainstream smartwatch sales, the company argues that protecting its patents safeguards years of clinical research and investment.
Whether consumers recognize the company or not, its intellectual property has become central to one of Silicon Valley’s biggest legal disputes.
Command: Consumer Impact Assessment
Current Apple Watch users are unlikely to experience immediate disruptions from this ruling.
However, future hardware designs, software implementations, and sensor capabilities could be influenced by ongoing legal negotiations and licensing requirements.
Patent litigation often shapes product roadmaps years before consumers notice changes.
Command: Industry-Wide Implications
Other wearable manufacturers are closely watching this case.
If courts continue applying broad interpretations to healthcare patents, technology companies may become more cautious before introducing new biometric sensors.
Licensing agreements could become increasingly common as firms seek to avoid billion-dollar legal risks.
Command: Financial Perspective
Although $634 million is relatively small compared to Apple’s overall financial resources, the symbolic importance of the verdict is significant.
A confirmed infringement finding may encourage additional patent holders to pursue litigation involving wearable health technologies.
For investors, precedent can sometimes matter more than the size of the damages.
Command: Innovation Versus Intellectual Property
Technology evolves rapidly, but patent law often protects inventions for decades.
This creates inevitable tension between innovation and ownership.
Courts increasingly serve as the final arbiters when technological evolution overlaps with existing intellectual property rights.
Command: Future Appeal Outlook
Apple’s appeal could focus on legal interpretation rather than technical functionality.
Appellate courts may revisit how patents define monitoring devices or examine whether procedural decisions during trial affected the outcome.
Until then, the existing verdict remains enforceable.
What Undercode Say:
Apple Faces a Symbolic Defeat
While Apple has the financial strength to absorb a $634 million judgment, the greater concern is the legal precedent. Losing a patent dispute involving healthcare technology can influence future litigation far beyond a single product.
Healthcare Technology Is Becoming a Legal Battlefield
The wearable market is rapidly moving closer to regulated medical devices. As companies add advanced sensors and AI-driven health analytics, patent conflicts are likely to become more frequent and significantly more expensive.
Innovation Alone Is No Longer Enough
Developing breakthrough features is only part of the challenge. Companies must also navigate thousands of existing patents, licensing agreements, and regulatory frameworks before bringing new health technologies to market.
Appeals Could Delay the Final Outcome
Apple’s decision to appeal suggests the case is far from over. Large technology companies often pursue multiple levels of judicial review before accepting substantial patent judgments.
Consumers Will Probably Notice Very Little
Despite dramatic legal headlines, everyday Apple Watch users are unlikely to see immediate changes. Apple has already demonstrated its willingness to redesign features rather than remove them permanently.
Medical Companies Gain More Negotiating Power
This ruling strengthens the negotiating position of specialized healthcare technology firms whose innovations are increasingly valuable to consumer electronics manufacturers.
Patent Portfolios Continue to Drive Competition
The modern technology race is no longer based solely on engineering talent. Ownership of foundational patents has become a strategic asset capable of shaping entire product categories.
Regulators and Courts Will Influence Future Innovation
Legal decisions may ultimately determine how quickly advanced health-monitoring features reach consumers. Courtroom outcomes increasingly affect engineering roadmaps.
Cross-Industry Collaboration May Increase
Instead of lengthy litigation, future partnerships between consumer technology companies and medical device manufacturers could become more attractive for both innovation and risk management.
The Wearable Industry Has Entered a New Era
Health-focused smart devices are evolving beyond fitness accessories into sophisticated monitoring platforms. As that transformation continues, patent enforcement will remain a defining force behind future competition.
✅ Confirmed: A federal judge denied
✅ Confirmed: The dispute stems from
❌ Not Yet Final: Apple has announced its intention to appeal, meaning the litigation is ongoing and the damages award could still be reviewed or modified by a higher court.
Prediction
(+1) Apple is likely to continue investing heavily in redesigned health-monitoring technologies that minimize future patent conflicts while preserving advanced wellness features for Apple Watch users.
(-1) If future appeals fail, the ruling could encourage additional patent holders to pursue similar lawsuits against major wearable technology companies, increasing legal costs and potentially slowing the rollout of new health innovations.
▶️ Related Video (82% Match):
🕵️📝Let’s dive deep and fact‑check.
🎓 Live Courses & Certifications:
Join Undercode Academy for Verified Certifications
🚀 Request a Custom Project:
Secure, high-velocity infrastructure and disruptive technological engineering. Contact our engineering team for high-tier development and proprietary systems:
[email protected]
💎 Smart Architecture | 🛡️ Secure by Design | ⭐ Trusted by Thousands
References:
Reported By: 9to5mac.com
Extra Source Hub (Possible Sources for article):
https://www.stackexchange.com
Wikipedia
OpenAi & Undercode AI
Image Source:
Unsplash
Undercode AI DI v2
🔐JOIN OUR CYBER WORLD [ CVE News • HackMonitor • UndercodeNews ]
📢 Follow UndercodeNews & Stay Tuned:
𝕏 formerly Twitter 🐦 | @ Threads | 🔗 Linkedin | 🦋BlueSky | 🐘Mastodon | 📺Youtube
